RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Revenue growth (%)

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndRevenue growth (%) YoY (%)
Dec 31, 2024-10.5-130.73%
Dec 31, 202334.1-223.86%
Dec 31, 2022-27.5-347.35%
Dec 31, 202111.1-131.76%
Dec 31, 2020-35-140.18%
Dec 31, 201987.2+381.24%
Dec 31, 201818.1-61.00%
Dec 31, 201746.5+109.47%
Dec 31, 201622.2-31.69%
Dec 31, 201532.5-28.50%
Dec 31, 201445.4+2.44%
Dec 31, 201344.3+1382.61%
Dec 31, 20123-134.57%
Dec 31, 2011-8.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)